NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science
In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General
“Our Job Is to Be The One Agency That Speaks To Cancer”
“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”
NCABP “Anyone With Same Facts Would Have Come To Same Conclusion
Prevention Trial Could Stand On Its Own
Chabner : Opportunity To Set Own Agenda Reason For Leaving
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









